Journal of Child

SUBMITINFORMATION
EnglishTürkçe

Research Article


DOI :10.26650/jchild.2023.1178024   IUP :10.26650/jchild.2023.1178024    Full Text (PDF)

Hepatitis B antibody Response in Patients with Celiac and Inflammatory Bowel Diseases

Didem Gülcü Taşkın

Objective: In some patient groups, special vaccination protocols need to be followed for vaccine preventable diseases like Hepatitis B (HB). We aimed to evaluate the antibody response against the HB vaccine in Inflammatory Bowel Disease (IBD) and Celiac Disease (CD) patients, emphasizing the efficiency of the routine vaccine protocol for these patient groups. Material and Methods: We included 219 patients (CD and IBD) and 125 in the healthy control group (HCG). The patients who had received only 3 doses of HB vaccine were included. The design of the study is retrospective in manner. Results: The patients age with positive antibody (anti-HBs titers) were lower than in patients with negative anti-HBs titers. In patients having positive anti-HBs titers, both the serum glutamic-oxaloacetic transaminase (SGOT) and serum glutamic-pyruvic transaminase (SGPT) values were found to be significantly higher. Result: Following periodic control measures and administering an additional dose of the HB vaccine is required because the antibody protection decreases as the illness continues to progress with the increasing age of the patients.

Keywords: Celiac disease (CD), Hepatitis B (HB) vaccine, antibody (AntiHBs titers), inflammatory bowel disease (IBD), pediatric
DOI :10.26650/jchild.2023.1178024   IUP :10.26650/jchild.2023.1178024    Full Text (PDF)

Çölyak Hastaları ve İnflamatuvar Bağırsak Hastalarında Hepatit B Antikor Yanıtı

Didem Gülcü Taşkın

Amaç: Bazı hasta gruplarında özellikle Hepatit B virüs enfeksiyonu gibi, aşı ile önlenebilen hastalıklar açısından özel aşılama protokollerine ihtiyaç vardır. Biz çalışmamızda İnflammatuvar Bağırsak Hastalığı (İBH) ve Çölyak Hastalığında (ÇH) Hepatit B aşı cevabını değerlendirerek bu hasta gruplarında kullanılan aşı protokolünün hastaları korumadaki etkinliğini araştırmak istedik. Gereç ve Yöntem: Çalışmaya toplam 219 kronik hastalığı olan çocuk (ÇH ve İBH) ve 125 sağlıklı (kontrol grubu) çocuk dahil edildi. Tüm gruplarda sadece 3 doz Hepatit B aşısı yapılmış olan hastalar çalışmaya dahil edilerek ek doz yapılmış ya da eksik doz uygulanmış hastalar çalışma dışında bırakıldı. Çalışma retrospektif olarak tasarlanmıştır. Bulgular: Çalışmaya dahil edilen hastaların anti HBs titreleri değerlendirildiğinde tüm gruplarda Anti HBs titresi pozitif olan hastaların yaş ortalamaları Anti HBs titresi negatif olan hastalara kıyasla daha düşük idi. Hastaların Anti HBs titresi pozitif olanlar değerlendirildiğinde Aspartat aminotransferaz (AST) ve Alanin aminotransferaz (ALT) değerleri daha yüksek bulundu. Sonuç: Hastalarda antikor koruyuculuğunun zamanla azaldığı gösterilmiştir. Özellikle infeksiyon açısından risk taşıyan, immunsüpresif ilaç kullanmak zorunda olan, ÇH ve İBH, gibi hasta gruplarında aşı titresi hastalık seyri sırasında belirli aralıklar ile takip edilmeli ve gerekirse ek doz aşılama düşünülmelidir.

Keywords: Çölyak Hastalığı (ÇH), Hepatit B virüs aşısı, Anti HBs antikor titresi, İnflammatuvar bağırsak hastalığı (İBH), çocuk

PDF View

References

  • 1. Di Sabatino A, Brunetti L, Carnevale MG, Giuffrida P, Corazza GR. Is it worth investigating splenic function in patients with celiac disease? World J Gastroenterol 2013;19:2313-18. google scholar
  • 2. Di Sabatino A, Rosado MM, Ciccocioppo R, Cazzola P, Morera R, Corazza GR, et al. Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease. Am J Gastroenterol 2005;100:1788-95. google scholar
  • 3. Gisbert JP, Chaparro M, Esteve M. Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011; 33:619-33. google scholar
  • 4. Carrera E, Manzano R, Garrido E. Efficacy of the vaccination in inflammatory bowel disease. World J Gastroenterol 2013;19:1349-53. google scholar
  • 5. Husby S, Koletzko S, Korponay-Szabo IR, Mearin ML, Phillips A, Shamir R, et al. European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012:54:136-60. google scholar
  • 6. Hepatitis B vaccines: WHO position paper—recommendations. Vaccine.2009;28:589-90. google scholar
  • 7. Zifman E, Zevit N, Heshin-Bekenstein M. Turner D, Shamir R, Silbermintz A. Efect of a Gluten Free Diet on Hepatitis B Surface Antibody Concentration in Previously Immunized Pediatric Celiac Patients. Pediatr. Gastroenterol. Hepatol. Nutr. 2020;23:132-6. google scholar
  • 8. Verso MG, Costantino C, Marrella A, Immordino P, Vitale F, Amodio E. Kinetics of Anti-Hepatitis B Surface Antigen Titers in Nurse Students after a Two-Year Follow-Up. Vaccines 2020;8:467-77. google scholar
  • 9. John TJ, Cooksley G. Hepatitis B vaccine boosters: is there a clinical need in high endemicity populations? J Gastroenterol Hepatol. 2005;20:5-10. google scholar
  • 10. Anania C, Olivero F, Spagnolo A, Chiesa C, Pacifco L. Immune response to vaccines in children with celiac disease. World J Gastroenterol. 2017;23:3205 google scholar
  • 11. Ertekin V, Tosun MS, Selimoglu MA. Is there need for a new hepatitis B vaccine schedule for children with celiac disease? Hepat Mon 2011;11:634-7. google scholar
  • 12. Sparks B, Salman S, Shull M, Trout A, Kiel A, Hill I, et al. A Celiac Care Index Improves Care of Pediatric Patients Newly Diagnosed with Celiac Disease. J Pediatr 2020;216:32-6. google scholar
  • 13. Dipasquale V, Romano C. Vaccination strategies in pediatric inflammatory bowel disease. Vaccine 2017;35:6070-75. google scholar
  • 14. Rahier JF, Ben-Horin S, Chowers Y, C Conlon, P De Munter, G D’Haens, et al. European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohn Colitis 2009;3:47-91. google scholar
  • 15. Passanisi S, Dipasquale V, Romano C. Vaccinations and Immune Response in Celiac Disease. Vaccines 2020;8:273-78. google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Taşkın, D.G. (2023). Hepatitis B antibody Response in Patients with Celiac and Inflammatory Bowel Diseases. Journal of Child, 23(1), 79-83. https://doi.org/10.26650/jchild.2023.1178024


AMA

Taşkın D G. Hepatitis B antibody Response in Patients with Celiac and Inflammatory Bowel Diseases. Journal of Child. 2023;23(1):79-83. https://doi.org/10.26650/jchild.2023.1178024


ABNT

Taşkın, D.G. Hepatitis B antibody Response in Patients with Celiac and Inflammatory Bowel Diseases. Journal of Child, [Publisher Location], v. 23, n. 1, p. 79-83, 2023.


Chicago: Author-Date Style

Taşkın, Didem Gülcü,. 2023. “Hepatitis B antibody Response in Patients with Celiac and Inflammatory Bowel Diseases.” Journal of Child 23, no. 1: 79-83. https://doi.org/10.26650/jchild.2023.1178024


Chicago: Humanities Style

Taşkın, Didem Gülcü,. “Hepatitis B antibody Response in Patients with Celiac and Inflammatory Bowel Diseases.” Journal of Child 23, no. 1 (Apr. 2024): 79-83. https://doi.org/10.26650/jchild.2023.1178024


Harvard: Australian Style

Taşkın, DG 2023, 'Hepatitis B antibody Response in Patients with Celiac and Inflammatory Bowel Diseases', Journal of Child, vol. 23, no. 1, pp. 79-83, viewed 16 Apr. 2024, https://doi.org/10.26650/jchild.2023.1178024


Harvard: Author-Date Style

Taşkın, D.G. (2023) ‘Hepatitis B antibody Response in Patients with Celiac and Inflammatory Bowel Diseases’, Journal of Child, 23(1), pp. 79-83. https://doi.org/10.26650/jchild.2023.1178024 (16 Apr. 2024).


MLA

Taşkın, Didem Gülcü,. “Hepatitis B antibody Response in Patients with Celiac and Inflammatory Bowel Diseases.” Journal of Child, vol. 23, no. 1, 2023, pp. 79-83. [Database Container], https://doi.org/10.26650/jchild.2023.1178024


Vancouver

Taşkın DG. Hepatitis B antibody Response in Patients with Celiac and Inflammatory Bowel Diseases. Journal of Child [Internet]. 16 Apr. 2024 [cited 16 Apr. 2024];23(1):79-83. Available from: https://doi.org/10.26650/jchild.2023.1178024 doi: 10.26650/jchild.2023.1178024


ISNAD

Taşkın, DidemGülcü. “Hepatitis B antibody Response in Patients with Celiac and Inflammatory Bowel Diseases”. Journal of Child 23/1 (Apr. 2024): 79-83. https://doi.org/10.26650/jchild.2023.1178024



TIMELINE


Submitted21.09.2022
Accepted07.02.2023
Published Online27.03.2023

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.